Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Aarti Drugs Limited
  6. News
  7. Summary
    524348   INE767A01016

AARTI DRUGS LIMITED

(524348)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Tranche Update on Aarti Drugs Limited's Equity Buyback Plan announced on March 19, 2021.

05/21/2021 | 04:09am EDT

From March 19, 2021 to May 10, 2021, the company has repurchased 600,000 shares, representing 0.64% for INR 600 million. With this, the company has completed the repurchase of 600,000 shares, representing 0.64% for INR 600 million under the buyback announced on March 19, 2021.


ę S&P Capital IQ 2021
All news about AARTI DRUGS LIMITED
07/28AARTI DRUGS' : Consolidated Profit Slumps Nearly 43% in Fiscal Q1
MT
07/27Aarti Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2021
CI
07/17Aarti Drugs Limited Announces Demise of Ramdas Maneklal Gandhi, Independent Director
CI
05/21Tranche Update on Aarti Drugs Limited's Equity Buyback Plan announced on March 19, 2021..
CI
05/17AARTI DRUGS' : Consolidated Profit Falls in Fiscal Q4
MT
05/15Aarti Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2021
CI
05/10Aarti Drugs Limited's Equity Buyback announced on March 19, 2021, has closed with 600,0..
CI
05/03AARTI DRUGS : Crisil Affirms Ratings on Aarti Drug's Bank Loan; Outlook Stable
MT
04/15AARTI DRUGS : ICRA Affirms Rating on Aarti Drugs' Term Loan; Outlook Stable
MT
03/28AARTI DRUGS : ICRA Givers AA- Rating on Aarti Drugs' Term Loan; Outlook Stable
MT
More news
Financials
Sales 2022 24 927 M 332 M 332 M
Net income 2022 2 861 M 38,1 M 38,1 M
Net Debt 2022 - - -
P/E ratio 2022 20,5x
Yield 2022 0,60%
Capitalization 57 625 M 769 M 768 M
Capi. / Sales 2022 2,31x
Capi. / Sales 2023 1,90x
Nbr of Employees 1 620
Free-Float 34,3%
Chart AARTI DRUGS LIMITED
Duration : Period :
Aarti Drugs Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AARTI DRUGS LIMITED
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 631,90 INR
Average target price 854,67 INR
Spread / Average Target 35,3%
EPS Revisions
Managers and Directors
Prakash Moreshwar Patil Chairman, CEO & Managing Director
Adhish P. Patil Chief Financial Officer
Rushikesh Deole Secretary & Compliance Officer
Vilas Gajanan Gaikar Independent Non-Executive Director
Bhavesh Rasiklal Vora Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
AARTI DRUGS LIMITED-10.43%781
JOHNSON & JOHNSON5.32%436 334
ROCHE HOLDING AG15.84%338 387
NOVO NORDISK A/S60.69%244 467
PFIZER, INC.17.22%244 227
ELI LILLY AND COMPANY47.15%225 231